Targeted Medical Pharma, Inc. is amedical nutrition company, which engages in the research, development, and commercialization of amino acid based medications. It operates through the following segments: Targeted Medical Pharma (TMP), Complete Claims Processing, Inc. (CCPI), and Amino Nutritionals. The TMP segment offers medical foods and generic pharmaceuticals as PTL. The CCPI segment includes point-of-care dispensing solutions; and billing, and collection services. The Amino Nutritionals segment produces and distributes amino acid based dietary supplements directly to consumers. Its products includes Theramine, AppTrim, and Hypertensa. The company was founded by Elizabeth Charuvastra, William E. Shell, and Kim Giffoni in 1999 and is headquartered in Los Angeles, CA.
Company profile
Ticker
TRGM
Exchange
Website
CEO
Marcus Charuvastra
Employees
Location
Fiscal year end
Industry (SIC)
Former names
AFH Acquisition III, Inc.
SEC CIK
Corporate docs
IRS number
205863618
TRGM stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
17 May 19
8-K
Departure of Directors or Certain Officers
22 Jan 19
15-12G
Securities registration termination
18 Oct 18
8-K
Departure of Directors or Certain Officers
12 Dec 17
10-K
2015 FY
Annual report
14 Apr 16
NT 10-K
Notice of late annual filing
31 Mar 16
10-Q
2015 Q3
Quarterly report
13 Nov 15
8-K
Changes in Registrant's Certifying Accountant
1 Oct 15
10-Q
2015 Q2
Quarterly report
14 Aug 15
10-Q
2015 Q1
Quarterly report
15 May 15
Latest ownership filings
3
Anthony Charuvastra
22 Apr 16
4
Thomas Richard Wenkart
8 Mar 16
4
Kim Giffoni
7 Mar 16
4
David Samuel Silver
7 Mar 16
4
Kerry Neil Weems
7 Mar 16
4
MAURICE J DEWALD
7 Mar 16
4
William B Horne
7 Mar 16
SC 13G/A
Targeted Medical Pharma, Inc.
17 Feb 16
4
Thomas Richard Wenkart
4 Feb 16
4
Olena B. Giffoni
24 Nov 15